Eye-cervical Re-education and Motor Control Training Program in Chronic Neck Pain

February 23, 2026 updated by: Riphah International University

Comparative Effects of an Eye-cervical Re-education and Motor Control Training Program on Pain, Range of Motion and Functional Disability in Chronic Neck Pain

The study was conducted to determine the comparative effects of an eye-cervical re-education and motor control training program on pain, range of motion and functional disability in chronic neck pain

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
52

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 05412
        • Rafiq Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Neck pain for minimum 3 months
  • Pain intensity on NPRS between 4 to 7
  • Limited neck range of motion
  • Medical diagnosis (Grade-II Neck pain) as per classification by "Bone and Joint Decade 2000-2010"
  • Cervical discomfort resulting from repetitive motion or prolonged postures.

Exclusion Criteria:

  • History of neck trauma/Fracture/Surgery/ Whiplash Injury
  • Systemic illness, rheumatic conditions, inflammatory joint disease
  • Other spine pathologies Cervical myelopathy / Fibromyalgia / Multiple Sclerosis/ Cervical radiculopathy
  • Tumor symptoms like high temperature, shivering, night pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Eye-cervical Re-education Program
Other: Eye-cervical Re-education Program
Eye-cervical Re-education program was carried out consisting of 10 proprioceptive reprogramming intervention steps : Activation of eye muscles, Passive cervical mobilization with fixed gaze, Active cervical mobility with directed gaze , Global cervical motion exercise , Neck mobility with the trunk , Head reposition exercise (Active), Head reposition exercise (Passive), Free coordination exercise, Manual resistance coordination exercise and Oculo-cervical coordination with soft stimuli. All exercises were done ten times each. 24 sessions were conducted for 8 weeks, with 3 sessions scheduled every week.
Other: Standardized Physiotherapy Treatment
Electric Hot pack and TENS having (200 µs pulse-width, 1Hz frequency) were applied for 10 minutes.
Active Comparator: Motor Control Training Program
Other: Standardized Physiotherapy Treatment
Electric Hot pack and TENS having (200 µs pulse-width, 1Hz frequency) were applied for 10 minutes.
Other: Motor Control Training Program
Motor Control Training Program was performed in supine position. It consisted of four parts, which include the cranio-cervical flexor exercise; co-contraction of neck flexors and extensors; the cranio-cervical extensor exercise; and the scapular re-education exercises. An air-filled cuff was put behind the neck and the patient tried to make five progressive positions with an increase in ROM i.e. to make improvements in pressure of 22, 24, 26, 28 and eventually 30 mmHg on pressure gauge. All exercises were done ten times each. 24 sessions were conducted for 8 weeks, with 3 sessions scheduled every week.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale
Time Frame: From enrollment to the end of treatment at 8 weeks
Numeric Pain Rating Scale is a subjective measure using which patient's rate their pain. It consists of 11 points, having an overall score ranging from 0 to 10, where: 0, 1 - 3, 4 - 6, 7 - 10 represents no pain, mild, moderate and the most severe pain respectively
From enrollment to the end of treatment at 8 weeks
Neck Disability Index in Urdu language
Time Frame: From enrollment to the end of treatment at 8 weeks
Neck pain disability index is used for the disability of the neck or the impact of neck pain on a person. It consists of 10 questions on pain intensity, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation. Performance in each item is described in 6 stages, from 0 to 5 points. The total of 0-4 points indicate no disability, 5-14 points indicate mild disability, 15-24 points indicate moderate disability, 25-34 points indicate severe disability and 35-50 points indicate complete disability
From enrollment to the end of treatment at 8 weeks
ROM Cervical spine (Flexion)
Time Frame: From enrollment to the end of treatment at 8 weeks
Changes in cervical spine flexion ROM at baseline and 8th week of intervention was measured using goniometer.
From enrollment to the end of treatment at 8 weeks
ROM Cervical Spine (Extension)
Time Frame: From enrollment to the end of treatment at 8 weeks
Changes in cervical spine extension ROM at baseline and 8th week of intervention was measured using goniometer.
From enrollment to the end of treatment at 8 weeks
ROM Cervical Spine (Lateral Flexion) Left Side
Time Frame: From enrollment to the end of treatment at 8 weeks
Changes in cervical spine lateral flexion on left side ROM at baseline and 8th week of intervention was measured using goniometer.
From enrollment to the end of treatment at 8 weeks
ROM Cervical Spine (Lateral Flexion) Right Side
Time Frame: From enrollment to the end of treatment at 8 weeks
Changes in cervical spine lateral flexion on right side ROM at baseline and 8th week of intervention was measured using goniometer.
From enrollment to the end of treatment at 8 weeks
ROM Cervical Spine (Rotation) Left Side
Time Frame: From enrollment to the end of treatment at 8 weeks
Changes in cervical spine rotation on left side ROM at baseline and 8th week of intervention was measured using goniometer.
From enrollment to the end of treatment at 8 weeks
ROM Cervical Spine (Rotation) Right Side
Time Frame: From enrollment to the end of treatment at 8 weeks
Changes in cervical spine rotation on right side ROM at baseline and 8th week of intervention was measured using goniometer.
From enrollment to the end of treatment at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Ali Raza, MS, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 13, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 31, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
October 31, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 23, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 23, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 27, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 27, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 23, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • REC/RCR & AHS/24/01102

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Neck Pain

Clinical Trials on Eye-cervical Re-education Program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings